Strados Labs offers innovative respiratory monitoring solutions, highlighted by their FDA-cleared RESP® Biosensor, the first wearable stethoscope designed for continuous monitoring of lung sounds, including cough and wheeze detection. This device allows for real-time data collection from patients, facilitating better management of lung health from hospital to home. Their technology not only provides clinicians with deeper insights into patient symptoms but also supports research studies and drug development in therapeutic areas such as asthma, chronic cough, COPD, and idiopathic pulmonary fibrosis (IPF). Strados Labs is committed to enhancing patient care through its seamless integration of cloud-based data storage and analysis.

Founded with the mission to improve respiratory health monitoring, Strados Labs has made significant strides in developing a user-friendly product that prioritizes patient comfort while accurately capturing vital health data. With a global reach across four continents and support in 35 languages, their technology is clinically validated against established benchmarks like the Littman 3200 digital stethoscope. The company operates offices in Philadelphia and Atlanta and continues to innovate solutions that make every breath count.